Diabetes Research Insights

Dave and Scott discuss the importance of compensating participants in research studies and the potential of novel biologics for preventing immune reactions in early-stage type 1 diabetes. Exciting updates on upcoming FDA decisions are shared, hinting at new possibilities in diabetes treatment.